Ace Therapeutics is a global leading provider of stroke research services. We specialize in comprehensive stroke drug development, offering services from target discovery to preclinical evaluation. Ace Therapeutics provides highly professional communication and flexible collaboration model to accelerate the drug discovery process in stroke better and faster.
Ace Therapeutics has multiple technology platforms related to biology and pharmacology to support a variety of drug discovery purposes for different types of stroke needs. Today, Ace Therapeutics can coordinate global resources and apply a multidisciplinary perspective to address the unique challenges of your stroke program. We focus on timeliness and accuracy at every stage of development.
We help you reach your stroke drug development decision-making milestones faster, improving the speed and ease of everything from lead candidate selection to proof of concept.
Leading pharmaceutical, biotechnology, and academic organizations around the world.
Our products and services cover basic research and the entire drug discovery and development process for stroke, and can be customized to meet specific research conditions.
Ace Therapeutics offers end-to-end solutions designed to provide a strategic advantage to your stroke drug development program. Our experienced team drives innovative stroke therapeutic development through the integrated application of in-house capabilities, including:
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.